Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Jason Adelstone
Nov 6, 2023
While the cannabis industry in the United States awaits a marijuana scheduling decision from the DEA, many countries around the world continue to move forward with liberalizing their cannabis policies as a superior method of promoting the health and welfare of their citizens. In this blog post, we’ll take a closer look at five countries poised to make waves in the cannabis landscape in 2024, including Germany, Thailand, Colombia, the Czech Republic, and Switzerland.
Oct 26, 2023
This recorded session features members of Vicente LLP’s Federal and International Law and Policy practice group and London cannabis attorney Robert Jappie of Fieldfisher sharing insights into what’s happening with cannabis and hemp-derived cannabinoids across the pond and opportunities for US operators and investors.
By Jason Adelstone
Mar 15, 2023
In its 2022 report, the International Narcotics Control Board (INCB) argues that legalizing the non-medical and non-scientific use of cannabis has failed to achieve the benefits to society that were intended through such legalization. In its attempt to deliver evidence of this failure, INCB instead provides ample evidence to the contrary—that legalization and regulation work. Read this insight for Vicente LLP’s response to the annual report of the INCB.
By Shane Pennington
Mar 1, 2023
How TGA's rescheduling of psilocybin and MDMA shines a bright light on DEA delinquency
By Shawn Hauser, Catie Wightman, Ariane Beckman
Sep 20, 2022
Like the US, regulators in the UK are struggling to find ways to best regulate CBD and other hemp-derived products—frustrating hemp businesses across the globe. Read this VS Insights article to learn how the UK is currently regulating CBD and key findings and recommendations from the ACMD's Consumer CBD Products Report.
Jul 28, 2022
The All-Party Parliamentary Group (APPG) for CBD Products recently delivered "A Plan for a Legal and Regulated UK Hemp and Cannabis Sector" to the UK Government. Shawn Hauser and Andrew Livingston contributed to the business plan, which offers an industry analysis and series of recommendations to create a well-regulated, multi-faceted and competitive UK cannabis industry.
By Jason Adelstone
Apr 27, 2022
A recent paper by Kenzi Riboulet-Zemouli argues that the 1961 Single Convention on Narcotic Drugs already allows for the regulation of Non-Medical cannabis. This premise, unfortunately, is just incorrect.
By Shane Pennington
Mar 25, 2022
Reps. Nancy Mace and Barbara Lee recently filed a resolution imploring President Biden to push the UN to remove cannabis from the list of controlled substances in the Single Convention on Narcotic Drugs of 1961. Taking this proposal seriously may prevent the DEA from placing hemp back on the federal CSA schedules.
By Vicente Sederberg LLP
May 24, 2021
Read the memo VS delivered to the International Narcotics Control Board, which gives draft guidelines on control requirements for medical and scientific cannabis and discusses the implications and important issues for consideration.
By Vicente Sederberg LLP
Dec 1, 2020
Read the memo VS delivered to the International Narcotics Control Board, which contests current international controls of CBD preparations and discusses the potential impacts of reform.